188 related articles for article (PubMed ID: 34522224)
1. CD4+ T cell-mimicking nanoparticles encapsulating DIABLO/SMAC mimetics broadly neutralize HIV-1 and selectively kill HIV-1-infected cells.
Campbell GR; Zhuang J; Zhang G; Landa I; Kubiatowicz LJ; Dehaini D; Fang RH; Zhang L; Spector SA
Theranostics; 2021; 11(18):9009-9021. PubMed ID: 34522224
[TBL] [Abstract][Full Text] [Related]
2. CD4
Zhang G; Campbell GR; Zhang Q; Maule E; Hanna J; Gao W; Zhang L; Spector SA
mBio; 2020 Sep; 11(5):. PubMed ID: 32934078
[TBL] [Abstract][Full Text] [Related]
3. DIABLO/SMAC mimetics selectively kill HIV-1-infected resting memory CD4
Campbell GR; Spector SA
Autophagy; 2019 Apr; 15(4):744-746. PubMed ID: 30653393
[TBL] [Abstract][Full Text] [Related]
4. SMAC Mimetics Induce Autophagy-Dependent Apoptosis of HIV-1-Infected Resting Memory CD4+ T Cells.
Campbell GR; Bruckman RS; Chu YL; Trout RN; Spector SA
Cell Host Microbe; 2018 Nov; 24(5):689-702.e7. PubMed ID: 30344003
[TBL] [Abstract][Full Text] [Related]
5. SMAC mimetics induce autophagy-dependent apoptosis of HIV-1-infected macrophages.
Campbell GR; To RK; Zhang G; Spector SA
Cell Death Dis; 2020 Jul; 11(7):590. PubMed ID: 32719312
[TBL] [Abstract][Full Text] [Related]
6. SMAC Mimetics as Therapeutic Agents in HIV Infection.
Molyer B; Kumar A; Angel JB
Front Immunol; 2021; 12():780400. PubMed ID: 34899741
[TBL] [Abstract][Full Text] [Related]
7. T-Cell-Mimicking Nanoparticles Can Neutralize HIV Infectivity.
Wei X; Zhang G; Ran D; Krishnan N; Fang RH; Gao W; Spector SA; Zhang L
Adv Mater; 2018 Nov; 30(45):e1802233. PubMed ID: 30252965
[TBL] [Abstract][Full Text] [Related]
8. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
Li H; Zony C; Chen P; Chen BK
J Virol; 2017 May; 91(9):. PubMed ID: 28148796
[TBL] [Abstract][Full Text] [Related]
9. Killing HIV-infected resting central memory CD4
Zhang G; Huang X
Antivir Chem Chemother; 2021; 29():2040206620980888. PubMed ID: 33557588
[TBL] [Abstract][Full Text] [Related]
10. Role of RIPK1 in SMAC mimetics-induced apoptosis in primary human HIV-infected macrophages.
Caballero RE; Dong SXM; Gajanayaka N; Ali H; Cassol E; Cameron WD; Korneluk R; Tremblay MJ; Angel JB; Kumar A
Sci Rep; 2021 Nov; 11(1):22901. PubMed ID: 34824340
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis.
Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
[TBL] [Abstract][Full Text] [Related]
12. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
13. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
Dupuy FP; Kant S; Barbé A; Routy JP; Bruneau J; Lebouché B; Tremblay C; Pazgier M; Finzi A; Bernard NF
mBio; 2019 Dec; 10(6):. PubMed ID: 31848282
[TBL] [Abstract][Full Text] [Related]
14. Selective cell death of latently HIV-infected CD4
Zhang G; Luk BT; Wei X; Campbell GR; Fang RH; Zhang L; Spector SA
Cell Death Dis; 2019 May; 10(6):419. PubMed ID: 31142734
[TBL] [Abstract][Full Text] [Related]
15. A Coreceptor-Mimetic Peptide Enhances the Potency of V3-Glycan Antibodies.
Fetzer I; Davis-Gardner ME; Gardner MR; Alfant B; Weber JA; Prasad NR; Zhou AS; Farzan M
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541842
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Respiration and Mitochondrial Dynamics by SMAC-Mimetics for Combination Therapy in Chemoresistant Cancer.
Hagenbuchner J; Oberacher H; Arnhard K; Kiechl-Kohlendorfer U; Ausserlechner MJ
Theranostics; 2019; 9(17):4909-4922. PubMed ID: 31410190
[TBL] [Abstract][Full Text] [Related]
17. Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.
Beltran-Pavez C; Bontjer I; Gonzalez N; Pernas M; Merino-Mansilla A; Olvera A; Miro JM; Brander C; Alcami J; Sanders RW; Sanchez-Merino V; Yuste E
J Virol; 2022 Jan; 96(1):e0134321. PubMed ID: 34668778
[TBL] [Abstract][Full Text] [Related]
18. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
[TBL] [Abstract][Full Text] [Related]
19. Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.
Richard J; Pacheco B; Gohain N; Veillette M; Ding S; Alsahafi N; Tolbert WD; Prévost J; Chapleau JP; Coutu M; Jia M; Brassard N; Park J; Courter JR; Melillo B; Martin L; Tremblay C; Hahn BH; Kaufmann DE; Wu X; Smith AB; Sodroski J; Pazgier M; Finzi A
EBioMedicine; 2016 Oct; 12():208-218. PubMed ID: 27633463
[TBL] [Abstract][Full Text] [Related]
20. Broadly Neutralizing Antibodies against HIV: Back to Blood.
Dashti A; DeVico AL; Lewis GK; Sajadi MM
Trends Mol Med; 2019 Mar; 25(3):228-240. PubMed ID: 30792120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
